vs
Side-by-side financial comparison of Allot Ltd. (ALLT) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $24.1M, roughly 2.0× Allot Ltd.). Allot Ltd. runs the higher net margin — -7.0% vs -33.9%, a 26.9% gap on every dollar of revenue. On growth, Allot Ltd. posted the faster year-over-year revenue change (8.5% vs -15.6%).
Allot Ltd., formerly Allot Communications, is an Israeli high-tech company that develops telecommunications software. The company is headquartered in Hod Hasharon, Israel.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
ALLT vs STEM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.1M | $47.1M |
| Net Profit | $-1.7M | $-16.0M |
| Gross Margin | 72.1% | 48.9% |
| Operating Margin | -1.7% | -17.7% |
| Net Margin | -7.0% | -33.9% |
| Revenue YoY | 8.5% | -15.6% |
| Net Profit YoY | 49.6% | 68.8% |
| EPS (diluted) | $-0.04 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $47.1M | ||
| Q3 25 | — | $38.2M | ||
| Q2 25 | $24.1M | $38.4M | ||
| Q1 25 | $23.1M | $32.5M | ||
| Q4 24 | — | $55.8M | ||
| Q3 24 | — | $29.3M | ||
| Q2 24 | $22.2M | $34.0M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | — | $-16.0M | ||
| Q3 25 | — | $-23.8M | ||
| Q2 25 | $-1.7M | $202.5M | ||
| Q1 25 | $-332.0K | $-25.0M | ||
| Q4 24 | — | $-51.1M | ||
| Q3 24 | — | $-148.3M | ||
| Q2 24 | $-3.4M | $-582.3M | ||
| Q1 24 | — | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | 72.1% | 33.4% | ||
| Q1 25 | 69.3% | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | 68.5% | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | — | -17.7% | ||
| Q3 25 | — | -33.6% | ||
| Q2 25 | -1.7% | -34.8% | ||
| Q1 25 | -3.1% | -65.0% | ||
| Q4 24 | — | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | -15.2% | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | — | -33.9% | ||
| Q3 25 | — | -62.2% | ||
| Q2 25 | -7.0% | 527.8% | ||
| Q1 25 | -1.4% | -76.9% | ||
| Q4 24 | — | -91.6% | ||
| Q3 24 | — | -506.3% | ||
| Q2 24 | -15.1% | -1712.6% | ||
| Q1 24 | — | -283.9% |
| Q4 25 | — | $-4.40 | ||
| Q3 25 | — | $-2.84 | ||
| Q2 25 | $-0.04 | $-1.79 | ||
| Q1 25 | $-0.01 | $-0.15 | ||
| Q4 24 | — | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | $-0.09 | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.1M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $99.7M | $-249.4M |
| Total Assets | $154.1M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | $60.1M | $40.8M | ||
| Q1 25 | $10.1M | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | $15.9M | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | — | $-249.4M | ||
| Q3 25 | — | $-235.7M | ||
| Q2 25 | $99.7M | $-214.1M | ||
| Q1 25 | $50.0M | $-417.5M | ||
| Q4 24 | — | $-398.4M | ||
| Q3 24 | — | $-344.1M | ||
| Q2 24 | $46.7M | $-203.2M | ||
| Q1 24 | — | $371.6M |
| Q4 25 | — | $308.9M | ||
| Q3 25 | — | $362.6M | ||
| Q2 25 | $154.1M | $379.2M | ||
| Q1 25 | $140.3M | $405.1M | ||
| Q4 24 | — | $437.4M | ||
| Q3 24 | — | $537.8M | ||
| Q2 24 | $132.5M | $691.5M | ||
| Q1 24 | — | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $8.2M |
| Free Cash FlowOCF − Capex | $4.0M | — |
| FCF MarginFCF / Revenue | 16.5% | — |
| Capex IntensityCapex / Revenue | 1.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | $4.4M | $-21.3M | ||
| Q1 25 | $1.7M | $8.5M | ||
| Q4 24 | — | $-14.7M | ||
| Q3 24 | — | $-9.4M | ||
| Q2 24 | $1.2M | $-11.9M | ||
| Q1 24 | — | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $4.0M | — | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $217.0K | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
